Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Online Intervention Promoting HPV Vaccination Among Chinese MSM

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04815837
Recruitment Status : Recruiting
First Posted : March 25, 2021
Last Update Posted : March 25, 2021
Sponsor:
Information provided by (Responsible Party):
Zixin Wang, Chinese University of Hong Kong

Brief Summary:
Hong Kong Chinese speaking men who have sex with men completed a baseline survey, and then received an online intervention promoting uptake of Human Papillomavirus (HPV) vaccination. All participants are followed up by telephone 12 months after the completion of baseline survey.

Condition or disease Intervention/treatment Phase
Vaccine Refusal Behavioral: Intervention Not Applicable

Detailed Description:

The primary objective of this study is to investigate prevalence of uptake of Human Papillomavirus (HPV) vaccination after exposure to health promotion among men who have sex with men in Hong Kong within a 12-month project period.

Inclusion criteria are Hong Kong Chinese speaking males aged 18-45 years old and self-reported having had oral or anal intercourse with at least one man in the last six months. Those who have ever received HPV vaccination are excluded.

Participants are recruited through outreaching in gay venues, online advertisement and referral made by peers and non-governmental organization. With verbal informed consent, participants completed a baseline survey through telephone. They are then exposed to online interventions including: 1) watching an online video, 2) receiving a discount coupon to receive HPV vaccination at collaborative private clinics, 3) visiting the project webpage, and 4) receiving follow-up reminders 1, 2, 4, 6, and 8 months after the baseline survey.

All participants are followed up by telephone 12 months after the baseline survey to access the primary outcome.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 350 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: An Evidence-based Knowledge Transfer Program Promoting Human Papillomavirus (HPV) Vaccination Among Men Who Have Sex With Men in Hong Kong
Actual Study Start Date : September 1, 2019
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021

Arm Intervention/treatment
Experimental: Intervention

Participants received the following interventions:

  1. Viewing a video promoting Human Papillomavirus (HPV) vaccination
  2. Receiving discount coupons
  3. Visiting the project webpage
  4. Receiving follow-up reminders
Behavioral: Intervention
  1. Viewing a video promoting Human Papillomavirus (HPV) vaccination: participants will watch a 5-minute online video promoting MSM's uptake of HPV vaccination. In the video, a peer MSM discussed about the risk of contracting HPV and having anal cancers among MSM, severe consequences of HPV-related diseases, as well as the benefits of HPV vaccination. He also demonstrated the procedures of taking up HPV vaccination in the collaborative private clinics, which portrayed caring, privacy guaranteed, and non-judgmental environment.
  2. Receiving the discount coupons: each participant will be given a discount coupon. By using the coupon, one can enjoy a 10% discount for taking up three doses of HPV vaccines at a collaborating private clinic.
  3. Visiting the project webpage: Participants can assess the project webpage by scanning the QR code on the discount coupon.
  4. Follow-up reminders: participants received five reminders at Month 1, 2, 4, 6, & 8.




Primary Outcome Measures :
  1. Taking up at least one dose of Human Papillomavirus (HPV) vaccination in the past year [ Time Frame: 12 months ]
    Participants report how many doses of HPV vaccines they have taken up in the past year.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Based on gender identity
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Hong Kong Chinese speaking males aged 18-45 years old and self-reported having had oral or anal intercourse with at least one man in the last six months

Exclusion Criteria:

  • Have received any HPV vaccination

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04815837


Contacts
Layout table for location contacts
Contact: Zixin Wang, PhD +852 22528740 wangzx@cuhk.edu.hk

Locations
Layout table for location information
Hong Kong
Centre for Health Behaviours Research, the Chinese University of Hong Kong Recruiting
Hong Kong, Hong Kong, 666888
Contact: Zixin Wang, PhD    +852 22528740    wangzx@cuhk.edu.hk   
Contact: Mary Ip, BSc    +852 22528724    mitk@cuhk.edu.hk   
Sponsors and Collaborators
Chinese University of Hong Kong
Investigators
Layout table for investigator information
Principal Investigator: Zixin Wang, PhD Chinese University of Hong Kong
Layout table for additonal information
Responsible Party: Zixin Wang, Assistant Professor, Chinese University of Hong Kong
ClinicalTrials.gov Identifier: NCT04815837    
Other Study ID Numbers: KPF18HLF22
First Posted: March 25, 2021    Key Record Dates
Last Update Posted: March 25, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Zixin Wang, Chinese University of Hong Kong:
HPV vaccination